GRTX
Galera Therapeutics, Inc. · Healthcare
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 5, 2026
Sorensen Mel
Galera Therapeutics, Inc. (GRTX) has 8 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 5, 2026.
Inside the rolling window, 1 insider at Galera Therapeutics, Inc. reported no open-market purchases and 1 open-market sale totaling $1K. The most recent open-market filing is a sale of 350 shares by President and CEO Sorensen Mel, dated Nov 20, 2025, worth $1K.
- Industry:Biotechnology
- CEO:J. Mel Sorensen
- Employees:3
- HQ:Malvern, PA, US
- IPO:2019-11-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
Sorensen MelFirst filing | President and CEO | Sale | 350 | $1K | Nov 24 | +270.0% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does GRTX have?
Galera Therapeutics, Inc. (GRTX) has 8 SEC Form 4 filings (11 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 5, 2026.
When was the most recent SEC Form 4 filing for GRTX?
The most recent Form 4 filing for GRTX on Tracefour is dated Aug 5, 2026.
What is the total insider buy and sell value at GRTX in the current window?
Inside the rolling window, insiders at GRTX bought $0 and sold $1K based on SEC Form 4 filings.
Can I get alerts for GRTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Galera Therapeutics, Inc. (GRTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Galera Therapeutics, Inc. is in the Healthcare sector.